Powered by: Motilal Oswal
1/12/2022 2:19:06 PM | Source: ICICI Direct Ltd
Hold PI Industries Ltd For Target Rs.3,930 - ICICI Direct
News By Tags | #872 #1660 #3961 #3568 #1302
Hold PI Industries Ltd For Target Rs.3,930 - ICICI Direct

Stellar numbers propelled by CSM…

About the stock: Incorporated in 1947, PI Industries focuses on complex chemistry solutions in agri and pharma sciences.

* The company maintains a strong research presence through its R&D facility in Udaipur, where it has a dedicated team of over 300 scientists

* The revenues of the company can be subdivided into custom synthesis manufacturing (CSM) and domestic agrochem formulation business with the former contributing ~74% to overall revenue in FY22 and the rest coming from the domestic formulations business

Q2FY23 Results: Numbers were above our estimates, led by strong volume growth from CSM and domestic.

* Reported revenue growth of 30.7% YoY to | 1770 crore, CSM (up 29% YoY). The revenue from domestic formulation was up 36% YoY to | 491.7 crore

* Gross margins stayed constant at ~45.2% while EBITDA margin expanded 284 bps YoY to 24.4%. Absolute EBITDA was up 48% YoY to | 431.9 crore

* PAT rose 46% YoY to | 334.8 crore, driven by strong operational efficiency

What should investors do? The stock appreciated at 37.3% CAGR in last three years.

* We downgrade the stock from BUY to HOLD as the current valuation more or less fully incorporates buoyant CSM outlook and domestic traction

Target Price and Valuation: We value PI Industries at 45x FY24E EPS to arrive at a revised target price of | 3930/share (earlier | 3710/share).

Key triggers for future price performance:

* Strong order backlog in CSM bodes well for future growth

* Proposed foray into pharma CDMO could expand revenue visibility further and diversify its revenue stream, to a certain extent

* Improvement in the operational performance owing to higher share of value added business portfolio to aid return ratios further

Alternate Stock Idea: Apart from PI Industries, in our chemical coverage, we also like Neogen Chemicals

* Trigger for Neogen Chemical’s future revenue growth would be increasing CRAMS opportunity

* BUY with a target price of | 1645

 

 

To Read Complete Report & Disclaimer Click Here

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here